Recent Quarter Total Invested
$9.52 M
Recent Quarter Institutional Ownership Percentage
54.41%
Total Invested of Last Quarter
$31.58 M
Ownership Percentage of Last Quarter
86.58%
Unicycive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 08/14/2024 | 3.47 M | $1.74 M | 0.00% | 9.94% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 3.47 M | $1.74 M | 0.00% | 9.94% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 2.82 M | $1.41 M | -15.45% | 8.08% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 2.63 M | $1.32 M | -24.16% | 7.54% |
| BVF INC/IL | 08/14/2024 | 2.20 M | $1.10 M | -39.09% | 6.30% |
| ROSALIND ADVISORS, INC. | 07/12/2024 | 1.57 M | $787,328 | -16.41% | 4.50% |
| VANGUARD GROUP INC | 08/13/2024 | 1.14 M | $570,362 | 234.91% | 3.26% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 08/12/2024 | 1.00 M | $501,100 | 0.00% | 2.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 285,738 | $143,182 | 12.85% | 0.82% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 93,352 | $46,779 | 0.01% | 0.27% |
| LPL FINANCIAL LLC | 08/07/2024 | 85,000 | $42,594 | 100.00% | 0.24% |
| BLACKROCK INC. | 08/13/2024 | 51,837 | $25,975 | 100.00% | 0.15% |
| STATE STREET CORP | 08/14/2024 | 43,936 | $22,016 | 25.40% | 0.13% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 33,200 | $16,637 | -64.25% | 0.10% |
| NORTHERN TRUST CORP | 08/14/2024 | 23,998 | $12,025 | 0.00% | 0.07% |
| CAPTRUST FINANCIAL ADVISORS | 08/15/2024 | 18,800 | $9,421 | 0.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 18,485 | $9,261 | 140.75% | 0.05% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 07/08/2024 | 15,500 | $7,084 | 0.00% | 0.04% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 11,094 | $6,000 | -57.46% | 0.03% |
| SCIENTECH RESEARCH LLC | 08/14/2024 | 10,969 | $5,497 | 100.00% | 0.03% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 08/09/2024 | 3,000 | $1,503 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 223 | $112 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 70 | $35 | 48.94% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 1 | $1 | -99.98% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 08/07/2024 | 0 | $0 | -100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Unicycive Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of UNCY shares?
During the previous two years, 29 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 3.47 M
Logos Global Management LP: 3.47 M
Nantahala Capital Management, LLC: 2.82 M
RA CAPITAL MANAGEMENT, L.P.: 2.63 M
BVF INC/IL: 2.2 M
Rosalind Advisors, Inc.: 1.57 M
-
What percentage of Unicycive Therapeutics, Inc. stock is owned by institutional investors?
54.41% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at UNCY ?
Institutional investors have bought a total of 19.02 M shares in the last 24 months. This purchase volume represents approximately $7.04 M in transactions.